Similar articles for PMID: 30418117

Year	Number of Results
1989	2
1991	2
1999	1
2001	1
2002	1
2003	3
2004	3
2005	2
2006	2
2007	2
2011	3
2012	7
2013	6
2014	6
2015	9
2016	18
2017	10
2018	16
2019	8
2020	3
2021	1
2022	1
2024	0

1

The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFRα-mAb treatment in rheumatoid arthritis patients.

Mortensen JH, Guo X, De Los Reyes M, Dziegiel MH, Karsdal MA, Bay-Jensen AC, White WI. Mortensen JH, et al. Clin Exp Rheumatol. 2019 Jan-Feb;37(1):73-80. Epub 2018 Nov 7. Clin Exp Rheumatol. 2019. PMID: 30418117

2

Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.

Guo X, Higgs BW, Bay-Jensen AC, Wu Y, Karsdal MA, Kuziora M, Godwood A, Close D, Ryan PC, Roskos LK, White WI. Guo X, et al. Rheumatology (Oxford). 2018 Jan 1;57(1):175-184. doi: 10.1093/rheumatology/kex383. Rheumatology (Oxford). 2018. PMID: 29069507 Clinical Trial.

3

A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.

Burmester GR, McInnes IB, Kremer J, Miranda P, Korkosz M, Vencovsky J, Rubbert-Roth A, Mysler E, Sleeman MA, Godwood A, Sinibaldi D, Guo X, White WI, Wang B, Wu CY, Ryan PC, Close D, Weinblatt ME; EARTH EXPLORER 1 study investigators. Burmester GR, et al. Ann Rheum Dis. 2017 Jun;76(6):1020-1030. doi: 10.1136/annrheumdis-2016-210624. Epub 2017 Feb 17. Ann Rheum Dis. 2017. PMID: 28213566 Free article. Clinical Trial.

4

Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safety.

Ryan PC, Sleeman MA, Rebelatto M, Wang B, Lu H, Chen X, Wu CY, Hinrichs MJ, Roskos L, Towers H, McKeever K, Dixit R. Ryan PC, et al. Toxicol Appl Pharmacol. 2014 Sep 1;279(2):230-9. doi: 10.1016/j.taap.2014.06.002. Epub 2014 Jun 15. Toxicol Appl Pharmacol. 2014. PMID: 24937321 Free article.

5

In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker.

Drobinski PJ, Nissen NI, Sinkeviciute D, Willumsen N, Karsdal MA, Bay-Jensen AC. Drobinski PJ, et al. Int J Mol Sci. 2022 Dec 24;24(1):321. doi: 10.3390/ijms24010321. Int J Mol Sci. 2022. PMID: 36613765 Free PMC article. Clinical Trial.

6

Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study.

Burmester GR, Feist E, Sleeman MA, Wang B, White B, Magrini F. Burmester GR, et al. Ann Rheum Dis. 2011 Sep;70(9):1542-9. doi: 10.1136/ard.2010.146225. Epub 2011 May 25. Ann Rheum Dis. 2011. PMID: 21613310 Free PMC article. Clinical Trial.

7

Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.

Li B, Li P, Bi L. Li B, et al. Clin Rheumatol. 2020 Mar;39(3):899-907. doi: 10.1007/s10067-019-04835-4. Epub 2019 Nov 22. Clin Rheumatol. 2020. PMID: 31758423

8

Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.

Cook AD, Louis C, Robinson MJ, Saleh R, Sleeman MA, Hamilton JA. Cook AD, et al. Arthritis Res Ther. 2016 Dec 1;18(1):287. doi: 10.1186/s13075-016-1185-9. Arthritis Res Ther. 2016. PMID: 27908288 Free PMC article.

9

Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: findings from a Phase IIa study.

Takeuchi T, Tanaka Y, Close D, Godwood A, Wu CY, Saurigny D. Takeuchi T, et al. Mod Rheumatol. 2015 Jan;25(1):21-30. doi: 10.3109/14397595.2014.896448. Epub 2014 Apr 11. Mod Rheumatol. 2015. PMID: 24720551 Clinical Trial.

10

Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.

Campbell J, Nys J, Eghobamien L, Cohen ES, Robinson MJ, Sleeman MA. Campbell J, et al. MAbs. 2016 Oct;8(7):1398-1406. doi: 10.1080/19420862.2016.1215790. Epub 2016 Aug 12. MAbs. 2016. PMID: 27560702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year